This site is intended for healthcare professionals
News

Fulcrum Therapeutics to evaluate losmapimod in Phase III trial as a potential treatment for COVID-19.

Read time: 2 mins
Last updated:11th Jun 2020
Published:11th Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com